SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Andre who wrote (4612)1/15/1998 5:42:00 PM
From: Anaxagoras  Read Replies (1) | Respond to of 23519
 
Sort of-
production is expected to be 1.8 million units from the old plant, as compared to the former quarterly rate of 2 million per quarter, if I understood correctly. Yes?

Anaxagoras



To: Andre who wrote (4612)1/15/1998 5:51:00 PM
From: Colby  Read Replies (1) | Respond to of 23519
 
My overall opinion of the conference call was optimistic. I was glad to see the company take measures not to "hype" upcoming events. I do believe the next quarter will be impacted (they alluded to this) because of marketing, but I will gladly sacrafice this quarter for the rest of the year. We could (beware: optimism ahead) benefit from unexpected product sale from the new plant if we do get MCA approval.
Hey, it could happen. In fact, I think it will, but again, that is nonsubstantiated optimism. This stock may not see much upside in the next few weeks, but watch out in Feb. I think we will see upside in anticipation of MCA approval and we will also benefit from some analysts jumping back on the wagon at that time. JMHO.

Very pleased,
Colby